A Study of AMD11070 in HIV-infected Patients Carrying X4-tropic Virus
This study has been completed.
Genzyme, a Sanofi Company
Information provided by:
First received: August 3, 2006
Last updated: February 10, 2014
Last verified: February 2014
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Study Completion Date:||April 2010|
|Primary Completion Date:||August 2006 (Final data collection date for primary outcome measure)|
Moyle G, DeJesus E, Boffito M, Wong RS, Gibney C, Badel K, MacFarland R, Calandra G, Bridger G, Becker S; X4 Antagonist Concept Trial Study Team. Proof of activity with AMD11070, an orally bioavailable inhibitor of CXCR4-tropic HIV type 1. Clin Infect Dis. 2009 Mar 15;48(6):798-805. doi: 10.1086/597097.